Blog

Continue Reading

  • New lizard species discovered with sharp, knife-like spines

    New lizard species discovered with sharp, knife-like spines

    Scientists have described a new lizard species from Vietnam, naming it Acanthosaura grismeri. The discovery adds a spiny backed member to a genus already rich in Southeast Asia and highlights how much biodiversity remains hidden in the…

    Continue Reading

  • Jofra Archer returns for England as New Zealand wins the toss and bowls in the 2nd cricket ODI – The Washington Post

    1. Jofra Archer returns for England as New Zealand wins the toss and bowls in the 2nd cricket ODI  The Washington Post
    2. ENG 175 (Jofra Archer 2(9) ) | New Zealand vs England, 2nd ODI, Today, England tour of New Zealand, 2025  Cricbuzz.com
    3. New Zealand…

    Continue Reading

  • Takehiro Hira Honored With The Hollywood Reporter’s Trailblazer Award

    Takehiro Hira Honored With The Hollywood Reporter’s Trailblazer Award

    Takehiro Hira‘s late career success streak continued on Tuesday night in Tokyo, as the in-demand Japanese actor was awarded The Hollywood Reporter‘s Trailblazer Award at a swanky gala event held at the sky-high Roppongi Hills Club.

    Continue Reading

  • Tata Motors confirms it fixed security flaws, which exposed company and customer data

    Tata Motors confirms it fixed security flaws, which exposed company and customer data

    Indian automotive giant Tata Motors has fixed a series of security flaws that exposed sensitive internal data, including personal information of customers, company reports, and data related to its dealers.

    Security researcher Eaton Zveare told…

    Continue Reading

  • Neural Dispatch: Agentic AI’s lack of intelligence, a DeepSeek moment, and Nvidia’s AI supercomputer 
(HT Tech)

    Neural Dispatch: Agentic AI’s lack of intelligence, a DeepSeek moment, and Nvidia’s AI supercomputer (HT Tech)

    Cognitive warmup. Is this another DeepSeek moment for AI to contend with? Chinese tech giants Alibaba says their Alibaba Cloud platform has successfully tested a new compute pooling system called Aegaeon, which has reduced the number of Nvidia…

    Continue Reading

  • Jofra Archer returns for England as New Zealand wins the toss and bowls in the 2nd cricket ODI

    Jofra Archer returns for England as New Zealand wins the toss and bowls in the 2nd cricket ODI

    HAMILTON, New Zealand (AP) — New Zealand won a delayed toss and chose to bowl Wednesday in the second one-day…

    Continue Reading

  • Thermo Fisher nears $10bn takeover of drug trial software maker Clario

    Thermo Fisher nears $10bn takeover of drug trial software maker Clario

    Stay informed with free updates

    Life sciences group Thermo Fisher is nearing a takeover of drug trial software maker Clario in a deal that could value the healthcare technology group at approximately $10bn.

    The all-cash deal could be announced as early as Wednesday provided it does not hit any last-minute snags, according to two people familiar with the matter.

    The acquisition would give Thermo Fisher access to a platform that is playing an increasingly critical role in managing the clinical data essential to drug trials. Clario’s technology has been used across 26,000 trials in more than 100 countries, generating as much as $400mn a year in adjusted earnings.

    If a sale materialises, it would mark one of the biggest full private equity exits of the year.

    Founded in 2021 by a merger of health tech groups ERT and Bioclinica, Clario is majority owned by Stockholm-based private equity group Nordic Capital. It also counts Astorg Partners, Novo Holdings and Cinven as minority investors. Clario’s private equity backers had until recently been considering a public listing for the group.

    Thermo Fisher, Clario, Nordic, Astorg, Novo Holdings and Cinven did not immediately respond to requests for comment.

    The deal would mark Thermo Fisher’s biggest acquisition since 2021 when the Massachusetts-based group bought contract research organisation PPD in a deal worth $17.4bn. Earlier this year, Thermo Fisher struck a $4.1bn deal to buy Solventum’s filtration unit.

    It comes amid a volatile period for Thermo Fisher and the wider healthcare sector. Shares in Thermo Fisher dropped earlier this year as investors fretted over the impact of President Donald Trump’s cuts to the National Institutes of Health on its sales, but they have since rallied.

    Thermo Fisher shares are up 6 per cent this year, giving it a market capitalisation of $210bn.

    Continue Reading

  • Women gain stronger heart protection from exercise than men, study reveals

    Women gain stronger heart protection from exercise than men, study reveals

    New research reveals that women achieve equal or greater protection from coronary heart disease and death with far less exercise than men, pointing to the need for personalized, sex-specific activity guidelines.

    Study: Sex…

    Continue Reading

  • Sia and ex’s custody battle escalates with drug and child porn claims

    Sia and ex’s custody battle escalates with drug and child porn claims

    Sia is responding to estranged husband Daniel Bernad’s “outrageous” filing for full physical and legal custody of their toddler son.

    The 49-year-old “Titanium” singer said Bernad’s emergency child custody request “should be denied in its entirety”…

    Continue Reading